| HLA | Region | HLA antigen allele | Relationship with TB | References |
| HLA-I gene | Canada | B8 | Susceptible | [6] | India | A2 | Susceptible | [7] | | B18 | Antagonized | [7] | Italy | A2, B14 | Antagonized | [8] | Iran | A26, B27 | Antagonized | [9] | | B17 | Susceptible | [9] | China | B27, B35 | Susceptible | [10] | | A31 | Antagonized | [10] |
| HLA-II gene | Govinda | DRB11302, DQB10301-0304 | Susceptible | [11] | Cambodia | DQ β57, DQB10301, -0303, DQB104 (-0401, -0402), DQB10503, DQB10601, -0602, -0603 | Susceptible | [12] | Iran | DRBI07, DQA10101 | Susceptible | [13] | Xiangxi, China | DRB109 | Susceptible | [14, 15] | | DRB111 | Antagonized | Xinjiang, China | DRB112 | Susceptible | [14, 15] | | DRB111 | Antagonized | Russia | DRB113 | Susceptible | [16] | India | DQB10503, -0502, DR2, DQB10601, DQ1, DRB11501 (DR2), DRB11501-DRB50101-DQA10103-DQB10601 | Susceptible | [4, 17, 18] | | DRW6 | Antagonized | [19] | Poland | DRB116, DQB105, DRB11601-DQB10502, DRB104-DQB103, DRB114-DQB105 | Susceptible | [20, 21] | | DRB113 | Antagonized | [20] |
|
|